Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. - Wikidata - awgldk - TriplyDB

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

http://www.wikidata.org/entity/Q43180169

about

New advances in hepatocellular carcinoma Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Current and future directions for treating hepatitis B virus infection Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy Emerging trends in hepatocellular carcinoma incidence and mortality.Surveillance for hepatocellular carcinoma.Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China Epidemiology of viral hepatitis and hepatocellular carcinoma Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.Markov modeling in hepatitis B screening and linkage to care Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection Viral Load Pattern Among Hepatitis B Surface Antigen-positive Patients: Laboratory Perspective and Implications for Therapy.Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics Successful resection of hepatocellular cancer not amenable to Milan criteria and durable complete remission induced by systemic polichemotherapy after development of metastases - should we think about revising the current treatment guidelines in sel Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Hepatocellular carcinoma: A global view.New perspectives of biomarkers for the management of chronic hepatitis B.Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.Natural history of chronic hepatitis B REVEALed.Review article: current antiviral therapy of chronic hepatitis B.

P2860

Q26749329-1525EA43-4114-4E4C-AD0C-EE63859AF85E Q26750444-7B308EE6-231A-448D-8686-EFF5C4FF48ED Q26766707-7DD72A1C-0A40-4A1B-9995-3D9A914F558D Q26851240-A4D62005-EE57-4DEF-B559-0ED7379B7CD3 Q27022899-8BFB07A9-8D55-4219-AA85-092459592340 Q27334932-1F48A06C-3C0D-4E34-8E7A-238C2465F631 Q27690269-A8A9B350-782B-4B38-9DAC-494F923EE575 Q28550643-650E73A3-B95C-4433-AE7B-8B2E80D2091D Q29617918-EF6C8116-A890-44DC-913C-DBFD94F8497A Q30251618-4EA9E851-AA08-48A1-9DD4-9DE7A82AF82A Q30391932-238C0097-5C06-4863-BF00-7DA3470A55B0 Q33391833-1715B679-EA38-4082-8910-7C8768D3FDBE Q33580037-AC8EC085-09C5-4198-88E9-BCD0CE414839 Q33706787-497E8C1E-8229-4C51-919C-C38C754C5741 Q34014518-795F68C8-234D-43BC-9166-06B75A12AB28 Q34137291-4E44F648-09F5-4235-BCD3-80DE1F471B41 Q34197835-456AD1AA-EEED-4686-8256-808E40A50402 Q34546701-C415C930-EDAE-4642-AC53-07A9764B9539 Q35036631-854C3F23-9541-4155-BA07-EC8624BBF451 Q35127050-6756B83E-F737-42EE-86AC-C09013EEF8EE Q35706571-CC1E3F5B-E9A4-4277-B8F5-DAB650BDA372 Q36016030-3E7AC99E-8119-425E-ADDB-D4464D3EFDAA Q36382856-B9C1D708-7977-445F-9B81-3D835041923A Q36883851-AED13878-F716-4438-B9E1-2F37638189A5 Q36899457-307D631B-BE2E-491C-AD88-4834520E96DE Q36924978-79256E40-0EC8-4211-AF69-C8C931B859CC Q36973383-EB1F5779-BC63-41E6-A41E-F6EE5BD63393 Q37138667-D71A5B1B-EADD-49D9-A9DE-88F415EAC7C9 Q37355835-5DE58610-8849-45FC-AC8E-3C766145AE25 Q37376515-DD08374D-077C-4EBC-B4D9-ED4A92EAD12E Q37381790-83C25C2D-F471-4EB0-81BF-1F8C6CF45909 Q37408912-2FCD65EF-6257-4CC3-ACFF-08281377D3DF Q37408920-F0C2D787-1155-4159-8018-F7B2FD5D2B38 Q37538505-35CB4242-88F5-40E9-970C-130A7FFB0A19 Q37589349-9E93CE04-14A0-4A73-9D8B-34F72CF8309F Q37606546-A6240DE5-898D-418E-B956-C4C728B0D3BF Q37663554-EAEA68FC-E710-4E90-B510-8D64E85FC6B2 Q37686490-EAF9DEE8-3D53-4F34-894F-5235D387DDED Q37842664-9E502CBD-FE3B-40AB-A620-D08B4C7B86F7 Q37943006-B8FC4D67-4D59-43B3-929A-CC52BC97A9A1

P2860

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

http://www.wikidata.org/entity/Q43180169

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Carriers of inactive hepatitis ...... inoma and liver-related death.

@en

Carriers of inactive hepatitis ...... inoma and liver-related death.

@nl

type

label

Carriers of inactive hepatitis ...... inoma and liver-related death.

@en

Carriers of inactive hepatitis ...... inoma and liver-related death.

@nl

prefLabel

Carriers of inactive hepatitis ...... inoma and liver-related death.

@en

Carriers of inactive hepatitis ...... inoma and liver-related death.

@nl

P1433

Q43180169-133B6FE6-4F2B-4855-A99A-87AE7EC842BE

P1476

Q43180169-F4BBC85B-CFC4-45BA-889A-73997F1B4DBD

P2093

Q43180169-036D2F4F-156C-40A6-978A-18170D08FA2D

Q43180169-197DD271-26A9-437E-AAC7-DD80C4190AC8

Q43180169-3F707446-771A-41CB-95A6-99A8682F5F71

Q43180169-4A00AA78-F6BA-4C8C-B167-B41FB8647F2C

Q43180169-604400A6-E9B6-43EB-9FEA-DFA6E43858C5

Q43180169-60B0D4D8-020F-4D33-A078-AD8C46642D12

Q43180169-63F8348E-7B1D-4A3C-BA3D-752ADCCF2502

Q43180169-D22FFFBC-A757-4F84-962F-6FEF06E37CFC

Q43180169-ECFE2FBF-99E2-4D43-AD13-3A42DEEC4036

P304

Q43180169-A9F20925-1607-4DF0-B385-D52521987D8D

P31

Q43180169-516A218D-401F-48B4-8AC2-F9F3C2951F74

P356

Q43180169-622B61CB-E083-47AF-94BA-A4813FCE1726

P407

Q43180169-4EDBCBE7-7BD4-4E6F-83E5-2BFE59468987

P433

Q43180169-EBCC89B4-2ECE-44C0-A133-03CAE5A08C31

P478

Q43180169-19989670-B44A-423D-B178-16FBBFD845BD

P50

Q43180169-714248fc-4176-ae12-9969-1b57d11d1f7a

Q43180169-84e22c82-4dd1-3565-d979-f64bc4500d95

P577

Q43180169-0E98DFA9-7BCB-49FC-97DC-977E159888FF

P698

Q43180169-A197AD49-5D2E-4110-A2A5-D3B0DAF8E0C5

P356

J.GASTRO.2010.01.042

P1433

Gastroenterology

P1476

Carriers of inactive hepatitis ...... inoma and liver-related death.

@en

P2093

Chien-An Sun

http://www.w3.org/2001/XMLSchema#string

Hwai-I Yang

http://www.w3.org/2001/XMLSchema#string

Jin-De Chen

http://www.w3.org/2001/XMLSchema#string

Jun Su

http://www.w3.org/2001/XMLSchema#string

Li-Yu Wang

http://www.w3.org/2001/XMLSchema#string

Risk Evaluation of Viral Load ...... n HBV (REVEAL-HBV) Study Group

http://www.w3.org/2001/XMLSchema#string

San-Lin You

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Lu

http://www.w3.org/2001/XMLSchema#string

Uchenna H Iloeje

http://www.w3.org/2001/XMLSchema#string

P304

1747-1754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.01.042

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20114048

http://www.w3.org/2001/XMLSchema#string